RUA vs. POLX, IHC, AVO, MHC, SUN, BELL, DEMG, SN, MXCT, and NIOX
Should you be buying RUA Life Sciences stock or one of its competitors? The main competitors of RUA Life Sciences include Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), Smith & Nephew (SN), MaxCyte (MXCT), and NIOX Group (NIOX). These companies are all part of the "medical devices" industry.
RUA Life Sciences vs.
Polarean Imaging (LON:POLX) and RUA Life Sciences (LON:RUA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings, community ranking and profitability.
RUA Life Sciences has a net margin of -65.72% compared to Polarean Imaging's net margin of -1,333.97%. RUA Life Sciences' return on equity of -26.38% beat Polarean Imaging's return on equity.
In the previous week, Polarean Imaging's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.
Polarean Imaging has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, RUA Life Sciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500.
RUA Life Sciences has lower revenue, but higher earnings than Polarean Imaging. RUA Life Sciences is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.
12.1% of Polarean Imaging shares are held by institutional investors. Comparatively, 26.0% of RUA Life Sciences shares are held by institutional investors. 39.3% of Polarean Imaging shares are held by company insiders. Comparatively, 51.3% of RUA Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Polarean Imaging received 23 more outperform votes than RUA Life Sciences when rated by MarketBeat users. Likewise, 67.65% of users gave Polarean Imaging an outperform vote while only 0.00% of users gave RUA Life Sciences an outperform vote.
Summary
RUA Life Sciences beats Polarean Imaging on 7 of the 13 factors compared between the two stocks.
Get RUA Life Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for RUA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
RUA Life Sciences Competitors List
Related Companies and Tools
This page (LON:RUA) was last updated on 2/22/2025 by MarketBeat.com Staff
Free RUA Stock Alerts